An efficient multiplex approach to CRISPR/Cas9 gene editing in citrus

被引:2
|
作者
Sagawa, Cintia H. D. [1 ]
Thomson, Geoffrey [1 ]
Mermaz, Benoit [1 ]
Vernon, Corina [1 ,2 ]
Liu, Siqi [1 ]
Jacob, Yannick [1 ]
Irish, Vivian F. [1 ]
机构
[1] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA
[2] CUNY, Adv Sci Res Ctr, Environm Sci Initiat, New York, NY USA
关键词
CRISPR/Cas9; Citrus; Multiplex; Gene editing; Vector design; GENOME;
D O I
10.1186/s13007-024-01274-4
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
CRISPR/Cas9-mediated gene editing requires high efficiency to be routinely implemented, especially in species which are laborious and slow to transform. This requirement intensifies further when targeting multiple genes simultaneously, which is required for genetic screening or more complex genome engineering. Species in the Citrus genus fall into this category. Here we describe a series of experiments with the collective aim of improving multiplex gene editing in the Carrizo citrange cultivar using tRNA-based sgRNA arrays. We evaluate a range of promoters for their efficacy in such experiments and achieve significant improvements by optimizing the expression of both the Cas9 endonuclease and the sgRNA array. In the case of the former we find the UBQ10 or RPS5a promoters from Arabidopsis driving the zCas9i endonuclease variant useful for achieving high levels of editing. The choice of promoter expressing the sgRNA array also had a large impact on gene editing efficiency across multiple targets. In this respect Pol III promoters perform especially well, but we also demonstrate that the UBQ10 and ES8Z promoters from Arabidopsis are robust alternatives. Ultimately, this study provides a quantitative insight into CRISPR/Cas9 vector design that has practical application in the simultaneous editing of multiple genes in Citrus, and potentially other eudicot plant species.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] The enhancement of CRISPR/Cas9 gene editing using metformin
    Rollins, Jaedyn L.
    Hall, Raquel M.
    Lemus, Clara J.
    Leisten, Lauren A.
    Johnston, Jennifer M.
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2023, 35
  • [42] CRISPR/CAS9 GENE EDITING APPLICATIONS IN CARDIOVASCULAR DISEASE
    Khouzam, J.
    Khouzam, R.
    Tivakaran, V.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (02) : 423 - 424
  • [43] Delivery methods for CRISPR/Cas9 gene editing in crustaceans
    Xu, Sen
    Pham, Thinh
    Neupane, Swatantra
    MARINE LIFE SCIENCE & TECHNOLOGY, 2020, 2 (01) : 1 - 5
  • [44] Therapeutic gene editing in haematological disorders with CRISPR/Cas9
    Jensen, Trine I.
    Axelgaard, Esben
    Bak, Rasmus O.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (05) : 821 - 835
  • [45] Lipid and polymer mediated CRISPR/Cas9 gene editing
    Gong, Yan
    Tian, Siyu
    Xuan, Yang
    Zhang, Shubiao
    JOURNAL OF MATERIALS CHEMISTRY B, 2020, 8 (20) : 4369 - 4386
  • [46] Gene editing using CRISPR/Cas9 in neuromuscular disorders
    Gonorazky, H.
    Maani, N.
    Khattak, S.
    Ivakine, Z.
    Cohn, R.
    Dowling, J.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S127 - S127
  • [47] Delivery methods for CRISPR/Cas9 gene editing in crustaceans
    Sen Xu
    Thinh Phu Pham
    Swatantra Neupane
    Marine Life Science & Technology, 2020, 2 : 1 - 5
  • [48] Fanconi Anemia Gene Editing by the CRISPR/Cas9 System
    Osborn, Mark J.
    Gabriel, Richard
    Webber, Beau R.
    DeFeo, Anthony P.
    McElroy, Amber N.
    Jarjour, Jordan
    Starker, Colby G.
    Wagner, John E.
    Joung, J. Keith
    Voytas, Daniel F.
    von Kalle, Christof
    Schmidt, Manfred
    Blazar, Bruce R.
    Tolar, Jakub
    HUMAN GENE THERAPY, 2015, 26 (02) : 114 - 126
  • [49] Xenotransplantation: The Contribution of CRISPR/Cas9 Gene Editing Technology
    Zoe A. Stewart
    Current Transplantation Reports, 2022, 9 : 268 - 275
  • [50] Xenotransplantation: The Contribution of CRISPR/Cas9 Gene Editing Technology
    Stewart, Zoe A.
    CURRENT TRANSPLANTATION REPORTS, 2022, 9 (04) : 268 - 275